Haleon (HLNCF) Other Non-Current Assets (2021 - 2025)
Haleon (HLNCF) recorded quarterly Other Non-Current Assets of $49.2 million in Q4 2025, down 45.99% on a QoQ basis from $91.1 million in Q4 2024, and down 45.99% year-over-year from $91.1 million in Q4 2024.
Haleon (HLNCF) Other Non-Current Assets (2021 - 2025) Analysis & Trends
Haleon has disclosed Other Non-Current Assets across 5 years of filings, most recently posting $49.2 million for Q4 2025.
- Quarterly Other Non-Current Assets fell 45.99% year-over-year to $49.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $49.2 million (down 45.99% YoY) and the FY2025 annual result came in at $48.8 million, down 46.25% from the prior year.
- Other Non-Current Assets fell to $49.2 million in Q4 2025, from $91.1 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $154.8 million in Q4 2022 and troughed at $10.8 million in Q4 2021.
- A 5-year average of $83.1 million and a median of $76.6 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 1335.69% — and 2023, when it sank 59.92%.
- Tracing HLNCF's Other Non-Current Assets over 5 years: stood at $10.8 million in 2021, then surged by 1335.69% to $154.8 million in 2022, then plunged by 59.92% to $62.1 million in 2023, then jumped by 46.85% to $91.1 million in 2024, then plunged by 45.99% to $49.2 million in 2025.
- Business Quant data shows HLNCF's Other Non-Current Assets at $49.2 million in Q4 2025, $91.1 million in Q4 2024, and $98.5 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Haleon | - | - | - | 49.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.22 Mn |
| Dec 31, 2024 | 91.13 Mn |
| Jun 30, 2024 | 98.45 Mn |
| Dec 31, 2023 | 62.06 Mn |
| Jun 30, 2023 | 141.40 Mn |
| Dec 31, 2022 | 154.83 Mn |
| Jun 30, 2022 | 56.67 Mn |
| Dec 31, 2021 | 10.78 Mn |